Pages that link to "Q34066697"
The following pages link to Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats (Q34066697):
Displaying 50 items.
- Cardiorenal syndrome: the emerging role of protein-bound uremic toxins (Q26830674) (← links)
- Adult cardiac expression of the activating transcription factor 3, ATF3, promotes ventricular hypertrophy (Q27311483) (← links)
- CARD9 as a potential target in cardiovascular disease (Q28066993) (← links)
- The fibrosis-cell death axis in heart failure (Q28076570) (← links)
- A-kinase-anchoring protein-Lbc anchors IκB kinase β to support interleukin-6-mediated cardiomyocyte hypertrophy (Q28116093) (← links)
- Natural product derivative BIO promotes recovery after myocardial infarction via unique modulation of the cardiac microenvironment (Q28597992) (← links)
- A comparative multi-parametric in vitro model identifies the power of test conditions to predict the fibrotic tendency of a biomaterial (Q33687188) (← links)
- Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis (Q34218604) (← links)
- Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF β/Smad activation and cardiac fibrosis induced by angiotensin II (Q34264496) (← links)
- Investigating the potential role of TRPA1 in locomotion and cardiovascular control during hypertension. (Q34292579) (← links)
- Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function (Q34304640) (← links)
- Modest elevation in BNP in asymptomatic hypertensive patients reflects sub-clinical cardiac remodeling, inflammation and extracellular matrix changes. (Q34477882) (← links)
- Deletion of interleukin-6 prevents cardiac inflammation, fibrosis and dysfunction without affecting blood pressure in angiotensin II-high salt-induced hypertension (Q34633337) (← links)
- Recurrent exposure to subclinical lipopolysaccharide increases mortality and induces cardiac fibrosis in mice (Q34667902) (← links)
- Diastolic dysfunction is associated with an increased risk of contrast-induced nephropathy: a retrospective cohort study (Q34816125) (← links)
- Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction (Q34873552) (← links)
- Dietary salt restriction improves cardiac and adipose tissue pathology independently of obesity in a rat model of metabolic syndrome (Q35115060) (← links)
- Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis (Q35151307) (← links)
- Myocardial fibrosis induced by exposure to subclinical lipopolysaccharide is associated with decreased miR-29c and enhanced NOX2 expression in mice (Q35261976) (← links)
- PKC δ and βII regulate angiotensin II-mediated fibrosis through p38: a mechanism of RV fibrosis in pulmonary hypertension (Q35437493) (← links)
- Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells (Q35538215) (← links)
- Qiliqiangxin inhibits angiotensin II-induced transdifferentiation of rat cardiac fibroblasts through suppressing interleukin-6 (Q35571961) (← links)
- Relationship between Inflammatory Cytokines and Indices of Cardiac Dysfunction following Intense Endurance Exercise (Q35662458) (← links)
- Type 1 diabetes increases the expression of proinflammatory cytokines and adhesion molecules in the artery wall of candidate patients for kidney transplantation (Q35688313) (← links)
- Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart. (Q35710032) (← links)
- Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure (Q35723859) (← links)
- Non-human primate and rat cardiac fibroblasts show similar extracellular matrix-related and cellular adhesion gene responses to substance P. (Q35821484) (← links)
- Autonomic neural regulation of the immune system: implications for hypertension and cardiovascular disease (Q35856337) (← links)
- Mesenchymal stem cell-derived inflammatory fibroblasts promote monocyte transition into myeloid fibroblasts via an IL-6-dependent mechanism in the aging mouse heart (Q35878968) (← links)
- Early Regulation of Profibrotic Genes in Primary Human Cardiac Myocytes by Trypanosoma cruzi. (Q35895021) (← links)
- Cardiac Dysfunction in the BACHD Mouse Model of Huntington's Disease (Q35903061) (← links)
- Prevention of adverse cardiac remodeling to volume overload in female rats is the result of an estrogen-altered mast cell phenotype. (Q35965003) (← links)
- Differential Effects of Prevention and Reversal Treatment with Lisinopril on Left Ventricular Remodelling in a Rat Model of Heart Failure (Q36042371) (← links)
- Human Cardiac Mesenchymal Stromal Cells with CD105+CD34- Phenotype Enhance the Function of Post-Infarction Heart in Mice. (Q36077608) (← links)
- β-Adrenergic receptors stimulate interleukin-6 production through Epac-dependent activation of PKCδ/p38 MAPK signalling in neonatal mouse cardiac fibroblasts (Q36159210) (← links)
- Pressure overload-induced cardiac remodeling and dysfunction in the absence of interleukin 6 in mice (Q36350716) (← links)
- THE AUTOCRINE ROLE OF TRYPTASE IN PRESSURE OVERLOAD-INDUCED MAST CELL ACTIVATION, CHYMASE RELEASE AND CARDIAC FIBROSIS. (Q36407381) (← links)
- Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome (Q36567326) (← links)
- Chronic treatment of mice with leukemia inhibitory factor does not cause adverse cardiac remodeling but improves heart function (Q36677145) (← links)
- Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGFβ1 and miR-29 pathways (Q36681664) (← links)
- Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease (Q36799689) (← links)
- Attenuation of cold stress-induced exacerbation of cardiac and adipose tissue pathology and metabolic disorders in a rat model of metabolic syndrome by the glucocorticoid receptor antagonist RU486. (Q36865075) (← links)
- Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling (Q36873593) (← links)
- TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis (Q36885519) (← links)
- Role of STAT3 in angiotensin II-induced hypertension and cardiac remodeling revealed by mice lacking STAT3 serine 727 phosphorylation (Q36906398) (← links)
- Cardiac-Specific Disruption of GH Receptor Alters Glucose Homeostasis While Maintaining Normal Cardiac Performance in Adult Male Mice (Q36911630) (← links)
- Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction (Q36994116) (← links)
- Signal Transducer and Activator of Transcription 3/MicroRNA-21 Feedback Loop Contributes to Atrial Fibrillation by Promoting Atrial Fibrosis in a Rat Sterile Pericarditis Model (Q37116392) (← links)
- Effect of Continuous Positive Airway Pressure on Cardiovascular Biomarkers: The Sleep Apnea Stress Randomized Controlled Trial. (Q37166381) (← links)
- Estrogen modulates the influence of cardiac inflammatory cells on function of cardiac fibroblasts (Q37190230) (← links)